4-1001695-C-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000203.5(IDUA):c.606C>G(p.Tyr202*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000025 in 1,600,618 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y202Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000203.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 1Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
- Scheie syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- Hurler syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Hurler-Scheie syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IDUA | NM_000203.5 | c.606C>G | p.Tyr202* | stop_gained | Exon 6 of 14 | ENST00000514224.2 | NP_000194.2 | |
| IDUA | NM_001363576.1 | c.210C>G | p.Tyr70* | stop_gained | Exon 5 of 13 | NP_001350505.1 | ||
| IDUA | XM_047415650.1 | c.606C>G | p.Tyr202* | stop_gained | Exon 6 of 12 | XP_047271606.1 | ||
| IDUA | NR_110313.1 | n.694C>G | non_coding_transcript_exon_variant | Exon 6 of 14 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.00000433 AC: 1AN: 230974 AF XY: 0.00000787 show subpopulations
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1448430Hom.: 0 Cov.: 34 AF XY: 0.00000416 AC XY: 3AN XY: 720944 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:2
- -
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1073056). This premature translational stop signal has been observed in individual(s) with clinical features of mucopolysaccharidosis type I (PMID: 12559846). This variant is present in population databases (no rsID available, gnomAD 0.001%). This sequence change creates a premature translational stop signal (p.Tyr202*) in the IDUA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IDUA are known to be pathogenic (PMID: 11735025, 21480867). -
Mucopolysaccharidosis, MPS-I-H/S Pathogenic:1
The stop gained p.Y202* in IDUA (NM_000203.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Y202* variant is observed in 1/1,05,660 (0.0009%) alleles from individuals of European (Non-Finnish) background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. For these reasons, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at